Clinical Trial

A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis.

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study is designed to evaluate the efficacy and safety of GenSci048 compared with placebo in subjects with active non-infectious uveitis.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-07-25
notable Enrollment reduced: 111 -> 74 participants 2026-07-25
minor Trial arms changed: 3 -> 2 2026-07-25
Trial Details
NCT Number NCT07547995
Lead Sponsor Changchun GeneScience Pharmaceutical Co., Ltd.
Conditions Uveitis
Enrollment 74 participants
Start Date 2026-06-29
Primary Completion 2027-12-14 (estimated)
Study Completion 2028-01-13 (estimated)
Updated on ClinicalTrials.gov 2026-07-24